Stay updated on BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Sign up to get notified when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.

Latest updates to the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page
- Check3 days agoChange DetectedLocations were expanded with many new sites across multiple regions, and prior location listings were removed. A new Revision: v3.3.3 tag was added.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded West Midlands and Greater London locations with updated site addresses and re-labeled London and Birmingham entries.SummaryDifference0.2%

- Check32 days agoChange DetectedPubMed publications note updated to indicate that publications are automatically filled from PubMed and may not all be about the study. Revision tag updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check40 days agoChange DetectedDeleted a government funding status notice about NIH operations displayed on the page; this does not affect the study details, eligibility, locations, or how a user would interact with the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedUpdated the study locations: Booker Dynamic Brand Solutions was added as a site in Atlanta, GA 30329. The Emory University School of Medicine Winship Cancer Institute site in Atlanta, GA 30322 was removed.SummaryDifference0.2%

- Check61 days agoChange DetectedNo significant changes detected on the BELINDA study page (NCT03570892); core study details appear unchanged and updates are likely minor UI adjustments.SummaryDifference0.3%

Stay in the know with updates to BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL
Enter your email address, and we'll notify you when there's something new on the BELINDA Clinical Trial: Tisagenlecleucel in B-cell NHL page.